172 related articles for article (PubMed ID: 38528382)
1. Hypersensitivity Reactions to Taxanes: A Multicenter Study for Outcomes and Safety of Rapid Drug Desensitization.
Bayrak Durmaz MS; Unutmaz DG; Demir M; Goksel O; Dursun AB; Bavbek S
Allergy Asthma Immunol Res; 2024 Mar; 16(2):142-153. PubMed ID: 38528382
[TBL] [Abstract][Full Text] [Related]
2. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.
Gorgulu Akin B; Erkoc M; Korkmaz ET; Ozdel Ozturk B; Colak S; Ozalp Ates FS; Bavbek S
World Allergy Organ J; 2022 Jan; 15(1):100619. PubMed ID: 34992710
[TBL] [Abstract][Full Text] [Related]
3. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
[TBL] [Abstract][Full Text] [Related]
4. Role of Skin Tests in the Diagnosis of Immediate Hypersensitivity Reactions to Taxanes: Results of a Multicenter Study.
Pagani M; Bavbek S; Dursun AB; Bonadonna P; Caralli M; Cernadas J; Cortellini G; Costantino MT; Gelincik A; Lucchini G; Castells M
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):990-997. PubMed ID: 30292919
[TBL] [Abstract][Full Text] [Related]
5. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
Picard M; Castells MC
Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
[TBL] [Abstract][Full Text] [Related]
6. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.
Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181
[TBL] [Abstract][Full Text] [Related]
8. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
Feldweg AM; Lee CW; Matulonis UA; Castells M
Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol.
Kim HH; Seo J; Ahn YH; Kim H; Yoon JE; Suh JH; Kang DY; Lee SY; Kang HR
Front Allergy; 2022; 3():786822. PubMed ID: 35386661
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of Desensitization.
Villarreal-González RV; González-Díaz S; Vidal-Gutiérrez O; Canel-Paredes A; de la Cruz-de la Cruz C; García-Campa M; López-Méndez A; Alvarado-Ruiz S; Castells M
Clin Rev Allergy Immunol; 2023 Oct; 65(2):231-250. PubMed ID: 37589840
[TBL] [Abstract][Full Text] [Related]
11. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
[TBL] [Abstract][Full Text] [Related]
12. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions.
Otani IM; Lax T; Long AA; Slawski BR; Camargo CA; Banerji A
J Allergy Clin Immunol Pract; 2018; 6(4):1266-1273.e2. PubMed ID: 28986119
[TBL] [Abstract][Full Text] [Related]
13. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of rapid drug desensitization in children.
Esenboga S; Akarsu A; Ocak M; Gur Cetinkaya P; Sahiner UM; Sekerel BE; Soyer O
Pediatr Allergy Immunol; 2022 Mar; 33(3):e13759. PubMed ID: 35338724
[TBL] [Abstract][Full Text] [Related]
15. Relevance of the diagnosis of hypersensitivity reactions to antineoplastic and biological agents: experience with drug provocation test.
Queirós Gomes J; Pereira Dias LP; Barreira P; Barradas Lopes J; Sousa MJ; Cadinha S; Malheiro D
Eur Ann Allergy Clin Immunol; 2023 May; ():. PubMed ID: 37133313
[No Abstract] [Full Text] [Related]
16. Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.
Goksel O; Goksel T; Cok G; Karakus H; Bacakoglu F; Goker E; Uslu R; Erdinc M
Int J Clin Oncol; 2015 Apr; 20(2):395-404. PubMed ID: 25056643
[TBL] [Abstract][Full Text] [Related]
17. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
[TBL] [Abstract][Full Text] [Related]
18. Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: Outcomes and risk factors.
Caiado J; Brás R; Paulino M; Costa L; Castells M
Ann Allergy Asthma Immunol; 2020 Sep; 125(3):325-333.e1. PubMed ID: 32353405
[TBL] [Abstract][Full Text] [Related]
19. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
[TBL] [Abstract][Full Text] [Related]
20. Management of Hypersensitivity Reactions to Taxanes.
Picard M
Immunol Allergy Clin North Am; 2017 Nov; 37(4):679-693. PubMed ID: 28965634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
